Court in Germany finds SEROQUEL XR® formulation patent invalid

[at noodls] – AstraZeneca today announced that the Federal Patent Court in Germany has found the formulation patent protecting SEROQUEL XR® (quetiapine fumarate) prolonged-release tablets – marketed as SEROQUEL Prolong … more

View todays social media effects on AZN

View the latest stocks trending across Twitter. Click to view dashboard